These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8258234)

  • 21. Cellular control of antinuclear antibody production. Anti-dsDNA and anti-Sm plaque forming cells in SLE patients and normal individuals.
    Weill BJ; Heavey AC; Evans J; Schur PH
    Clin Exp Rheumatol; 1985; 3(1):39-47. PubMed ID: 3884204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
    Sulcebe G; Morcka K
    Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The lupus band test in the diagnosis of systemic lupus erythematosus: its decisive usefulness in cases negative for anti-ds-DNA and anti-SM].
    Scarpa R; Carrela M; Casiere D; Larizza G; Del Puente A; di Girolamo C; della Valle G; Oriente P
    Recenti Prog Med; 1990 Dec; 81(12):812-5. PubMed ID: 2075287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.
    Eisenberg RA; Dyer K; Craven SY; Fuller CR; Yount WJ
    J Clin Invest; 1985 Apr; 75(4):1270-7. PubMed ID: 3872886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Sm and anti-RNP antibodies.
    Migliorini P; Baldini C; Rocchi V; Bombardieri S
    Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity.
    Emad Y; Gheita T; Darweesh H; Klooster P; Gamal R; Fathi H; El-Shaarawy N; Gamil M; Hawass M; El-Refai RM; Al-Hanafi H; Abd-Ellatif S; Ismail A; Rasker J
    Reumatismo; 2018 Jul; 70(2):85-91. PubMed ID: 29976042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay.
    Mahler M; Stinton LM; Fritzler MJ
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):107-13. PubMed ID: 15642993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis.
    Alba P; Bento L; Cuadrado MJ; Karim Y; Tungekar MF; Abbs I; Khamashta MA; D'Cruz D; Hughes GR
    Ann Rheum Dis; 2003 Jun; 62(6):556-60. PubMed ID: 12759294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus.
    Al-Jabri AA; Al-Gahdani AK; Al-Shuaili I
    Rheumatol Int; 2009 Nov; 30(1):51-6. PubMed ID: 19360411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA, and SSB).
    Froelich CJ; Wallman J; Skosey JL; Teodorescu M
    J Rheumatol; 1990 Feb; 17(2):192-200. PubMed ID: 2108246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large speckle-like thready and thready antinuclear antibody patterns as markers for different clinical presentations in lupus erythematosus.
    Nordby CA; Pelachyk JM; Burnham TK
    J Am Acad Dermatol; 1987 Sep; 17(3):427-33. PubMed ID: 3308979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of anti-Sm antibody analysis].
    Tojo T; Ogasawara T
    Nihon Rinsho; 1990 Feb; 48 Suppl():497-500. PubMed ID: 2113132
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus.
    Vilá LM; Molina MJ; Mayor AM; Peredo RA; Santaella ML; Vilá S
    Lupus; 2006; 15(12):892-8. PubMed ID: 17211998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis.
    Smolen JS; Hassfeld W; Graninger W; Steiner G
    Clin Exp Rheumatol; 1990; 8 Suppl 5():41-4. PubMed ID: 2245525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential development of antibodies to specific Sm polypeptides in a patient with systemic lupus erythematosus: evidence for independent regulation of anti-double-stranded DNA and anti-Sm antibody production.
    ter Borg EJ; Horst G; Hummel E; Jaarsma D; Limburg PC; Kallenberg CG
    Arthritis Rheum; 1988 Dec; 31(12):1563-7. PubMed ID: 2461714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus.
    Boey ML; Peebles CL; Tsay G; Feng PH; Tan EM
    Ann Rheum Dis; 1988 Nov; 47(11):918-23. PubMed ID: 3264694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of multiplex immune assay of antinuclear antibodies in systemic lupus erythematosus.].
    Aleksandrova EN; Verizhnikova ZG; Novikov AA; Panafidina TA; Popkova TV; Lukina GV
    Klin Lab Diagn; 2018; 63(7):434-438. PubMed ID: 30720960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation of Sm antibodies and clinical symptoms in systemic lupus erythematosus].
    Serfling U; Brenke A; Ziegler H; Barthelmes H; Sönnichsen N
    Dermatol Monatsschr; 1988; 174(11):667-70. PubMed ID: 3264793
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunization of nonautoimmune mice with DNA binding domains of the largest subunit of RNA polymerase I results in production of anti-dsDNA and anti-Sm/RNP antibodies.
    Sciascia SA; Robson K; Zhu L; Garland M; Grabosch S; Kelamis J; Messamore W; Bradley T; Sourk A; Westberg L; Goodnight W; Tongson K; Holloway N; Wardak Z; Sudyka M; Masrani S; Chintalapati S; Cagaanan M; Brown JC; Stetler DA
    Autoimmunity; 2007 Feb; 40(1):38-47. PubMed ID: 17364496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis).
    Ishii M; Muramoto Y; Kosaka H; Ohshima S; Mima T; Katada Y; Hirohata S; Saeki Y
    Lupus; 2007; 16(1):67-9. PubMed ID: 17283590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.